Substance P/Neurokinin-1 Receptor Antagonist class drugs

3 results

  • akynzeo

    (Netupitant and Palonosetron)
    Helsinn Therapeutics (U.S.), Inc.
    AKYNZEO is indicated for the prevention of acute and delayed nausea and vomiting in adults undergoing initial and repeat courses of highly emetogenic cancer chemotherapy, used in combination with dexamethasone. It consists of palonosetron and netupitant (or fosnetupitant in injectable form).
    Medication Details
    Drug Interactions

  • aprepitant

    (Aprepitant)
    Glenmark Pharmaceuticals Inc., USA
    Aprepitant is indicated for preventing chemotherapy-induced nausea and vomiting (CINV) in patients aged 12 and older undergoing highly or moderately emetogenic chemotherapy, and for preventing postoperative nausea and vomiting (PONV) in adults. It is not intended for treating established nausea and vomiting.
    Medication Details
    Drug Interactions

  • varubi

    (rolapitant)
    TerSera Therapeutics LLC
    VARUBI® is indicated for the prevention of delayed nausea and vomiting in adults undergoing emetogenic cancer chemotherapy, in combination with other antiemetic agents. This includes initial and repeat courses of highly emetogenic chemotherapy.
    Medication Details
    Drug Interactions